Viatris, Kindeva Drug Delivery Have Launched Breyna (Budesonide, Formoterol Fumarate Dihydrate) Inhalation Aerosol, First Generic Version Of AstraZeneca's Symbicort Indicated For Certain Patients With Asthma Or Chronic Obstructive Pulmonary Disease
Portfolio Pulse from Benzinga Newsdesk
Viatris and Kindeva Drug Delivery have launched Breyna, the first generic version of AstraZeneca's Symbicort. The inhalation aerosol is indicated for certain patients with asthma or chronic obstructive pulmonary disease.
July 31, 2023 | 11:04 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AstraZeneca's Symbicort now has a generic competitor in the form of Breyna, launched by Viatris. This could potentially impact AstraZeneca's market share and revenues from Symbicort.
The introduction of a generic version of Symbicort could potentially decrease AstraZeneca's market share and revenues from this drug, as patients might opt for the cheaper alternative. This could have a negative impact on AstraZeneca's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Viatris has launched Breyna, a generic version of AstraZeneca's Symbicort. This could potentially increase Viatris' market share in the respiratory disease treatment sector.
The launch of a generic version of a popular drug can potentially increase Viatris' market share and revenues, as it provides a cheaper alternative for patients. This could have a positive impact on Viatris' stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100